Research programme: antifungals - Cytomics Systems
Alternative Names: CC 0105; CC 0262; CSY 001; CYD 1274Latest Information Update: 07 Jan 2011
At a glance
- Originator Cytomics Systems
- Class
- Mechanism of Action Ubiquitin protein ligase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 07 Jan 2011 Discontinued - Preclinical for Mycoses in France (unspecified route)
- 11 Jun 2005 Preclinical trials in Mycoses in France (unspecified route)